MiQro Era develops quantum computing software and applications for biomedicine and materials.
Founded in 2022 in Hefei, China, MiQro Era develops quantum computing algorithms and industry applications for fields including biomedicine and new materials. Its products include the MiQro RNA drug design platform, quantum computing systems and drug screening technology. In January 2026, it raised approximately CNY 100 million in Series A funding led by Winreal Investment, with Spinel Capital and individual investors participating. Jiangxi Geto New Materials Corporation Limited made an earlier strategic investment in April 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in